Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Conteduca

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2018
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?Delia De Lisi, Ugo De Giorgi, Cristian Lolli, et al.
Cancers|December 11, 2019
The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer TreatmentNicole Brighi, Alberto Farolfi, Vincenza Conteduca, et al.
The Journal of Rheumatology|December 3, 2013
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitisDomenico Sansonno, Sabino Russi, Gaetano Serviddio, et al.
Endocrine-Related Cancer|April 18, 2014
Chromogranin A predicts outcome in prostate cancer patients treated with abirateroneSalvatore Luca Burgio, Vincenza Conteduca, Cecilia Menna, et al.
Expert Review of Molecular Diagnostics|May 27, 2021
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNAVincenza Conteduca, Nicole Brighi, Donato Conteduca, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 29, 2024
TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cellsGiuseppina Bruno, Michele Pietrafesa, Fabiana Crispo, et al.
The International Journal of Biological Markers|March 9, 2016
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abirateroneSamanta Salvi, Valentina Casadio, Salvatore Luca Burgio, et al.
BMC Medical Genomics|August 4, 2019
Identification of single nucleotide variants using position-specific error estimation in deep sequencing dataDimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2009
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damageDomenico Sansonno, Felicia Anna Tucci, Berhane Ghebrehiwet, et al.
Cancers|May 14, 2022
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or EnzalutamideVincenza Conteduca, Chiara Casadei, Emanuela Scarpi, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2018
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?Delia De Lisi, Ugo De Giorgi, Cristian Lolli, et al.
Cancers|December 11, 2019
The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer TreatmentNicole Brighi, Alberto Farolfi, Vincenza Conteduca, et al.
The Journal of Rheumatology|December 3, 2013
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitisDomenico Sansonno, Sabino Russi, Gaetano Serviddio, et al.
Endocrine-Related Cancer|April 18, 2014
Chromogranin A predicts outcome in prostate cancer patients treated with abirateroneSalvatore Luca Burgio, Vincenza Conteduca, Cecilia Menna, et al.
Expert Review of Molecular Diagnostics|May 27, 2021
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNAVincenza Conteduca, Nicole Brighi, Donato Conteduca, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 29, 2024
TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cellsGiuseppina Bruno, Michele Pietrafesa, Fabiana Crispo, et al.
The International Journal of Biological Markers|March 9, 2016
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abirateroneSamanta Salvi, Valentina Casadio, Salvatore Luca Burgio, et al.
BMC Medical Genomics|August 4, 2019
Identification of single nucleotide variants using position-specific error estimation in deep sequencing dataDimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2009
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damageDomenico Sansonno, Felicia Anna Tucci, Berhane Ghebrehiwet, et al.
Cancers|May 14, 2022
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or EnzalutamideVincenza Conteduca, Chiara Casadei, Emanuela Scarpi, et al.
Pageof 16